Transaction · 0001395064-26-000335

Plump Andrew Stewart

Plump Andrew Stewart, PRES, R, D, reported an open-market or private sale at TAKEDA PHARMACEUTICAL CO LTD involving 116191.000000 shares for an estimated $2148371.59. Reported holdings after the transaction were 145465.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, R, D
TAKTAKEDA PHARMACEUTICAL CO LTD
Trade date
Sep 02, 2026
Filing date
Sep 04, 2026
View on SEC Insider profile
Estimated value-$2.14MShares × reported price
Shares traded116k$18.49 per share
Holdings after145kIndirect · By Trust
% of reported position traded44.41%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 261,656 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TAK price since this filing

Daily closing prices, with the filing date and available return windows
TAK · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -8.8%1w ago -1.2%1d ago -1.2%
Returns since7d -1.0%30d -3.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001395064-26-000335
American Depositary Shares
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 01:49 AM · 2d delay
Shares
116,191 sh
$18.49 per share
Estimated value
-$2.14M
Computed from shares × price
Holdings after
145,465 sh
Indirect · By Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Reduction Large Sale Repeat Seller 10b5-1 Detected
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, R&D

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.

Original filing · 0001395064-26-000335
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TAK